Greenwich LifeSciences (GLSI) Short Interest Ratio & Short Volume → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free GLSI Stock Alerts $13.19 -0.21 (-1.57%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Greenwich LifeSciences Short Interest DataCurrent Short Interest177,100 sharesPrevious Short Interest189,100 sharesChange Vs. Previous Month-6.35%Dollar Volume Sold Short$2.61 millionShort Interest Ratio4.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares12,880,000 sharesFloat Size5,850,000 sharesShort Percent of Float3.03%Today's Trading Volume22,034 sharesAverage Trading Volume41,593 sharesToday's Volume Vs. Average53% Short Selling Greenwich LifeSciences ? Sign up to receive the latest short interest report for Greenwich LifeSciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLSI Short Interest Over TimeGLSI Days to Cover Over TimeGLSI Percentage of Float Shorted Over Time Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… Greenwich LifeSciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024177,100 shares $2.61 million -6.4%3.0%4.1 $14.75 4/30/2024189,100 shares $2.35 million +2.2%3.2%3.6 $12.42 4/15/2024185,100 shares $2.64 million +31.7%3.2%3.6 $14.26 3/31/2024140,500 shares $2.80 million +2.5%2.4%2.9 $19.94 3/15/2024137,100 shares $2.40 million +13.0%2.4%3 $17.50 2/29/2024121,300 shares $1.48 million -30.1%2.1%3.2 $12.16 Get the Latest News and Ratings for GLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024173,600 shares $2.01 million +12.4%3.0%5.5 $11.60 1/31/2024154,500 shares $1.33 million -4.2%2.6%8.1 $8.64 1/15/2024161,200 shares $1.49 million +5.8%2.8%9.2 $9.26 12/31/2023152,300 shares $1.60 million +32.8%2.6%9.5 $10.52 12/15/2023114,700 shares $1.23 million -31.3%2.0%7.9 $10.76 11/30/2023167,000 shares $1.95 million +0.1%2.9%11.6 $11.70 11/15/2023166,800 shares $1.83 million +2.0%2.9%12.4 $10.98 10/31/2023163,500 shares $1.37 million -11.3%2.8%12.7 $8.36 10/15/2023184,300 shares $1.59 million -5.5%3.1%13.8 $8.64 9/30/2023195,100 shares $1.72 million +0.1%3.3%14.2 $8.84 9/15/2023194,900 shares $1.76 million +7.9%3.3%12.8 $9.04 8/31/2023180,700 shares $1.66 million -3.4%3.1%10.2 $9.17 8/15/2023187,000 shares $1.99 million +5.2%3.2%9.4 $10.66 7/31/2023177,800 shares $1.64 million -4.6%3.0%8.6 $9.20 7/15/2023186,300 shares $1.74 million -4.7%3.2%7.8 $9.34 6/30/2023195,500 shares $1.89 million -12.7%3.3%5.2 $9.65 6/15/2023224,000 shares $2.47 million -1.0%3.8%5.5 $11.04 5/31/2023226,200 shares $2.46 million -6.5%6.3%5.5 $10.89 5/15/2023242,000 shares $2.72 million -21.7%6.8%5.6 $11.25 4/30/2023308,900 shares $3.31 million -9.2%8.6%6.7 $10.71 4/15/2023340,000 shares $4.02 million +23.3%9.5%6.9 $11.81 3/31/2023275,700 shares $3.80 million +43.2%7.7%6.3 $13.79 3/15/2023192,500 shares $2.49 million +9.9%5.4%4.7 $12.92 2/28/2023175,100 shares $2.73 million -1.1%4.9%4.4 $15.61 2/15/2023177,100 shares $2.98 million -2.2%4.9%4.1 $16.85 1/31/2023181,100 shares $3.59 million -9.8%5.0%4 $19.84 1/15/2023200,800 shares $3.27 million -10.6%5.6%4.5 $16.26 12/30/2022224,600 shares $3.41 million +15.6%6.2%5.3 $15.20 12/15/2022194,300 shares $2.52 million -17.8%5.4%5 $12.97 11/30/2022236,400 shares $3.30 million +0.2%6.6%5.5 $13.95 11/15/2022235,900 shares $2.61 million +26.5%6.6%5.8 $11.08 10/31/2022186,500 shares $1.68 million -21.6%5.2%4.4 $9.01 10/15/2022238,000 shares $2.35 million -10.6%6.6%4.9 $9.86 9/30/2022266,200 shares $2.42 million +3.5%24.0%1.2 $9.10Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. 9/15/2022257,100 shares $2.66 million +10.6%23.2%1.1 $10.35 8/31/2022232,400 shares $2.20 million +19.5%18.3%0.9 $9.48 8/15/2022194,500 shares $2.02 million -34.6%15.1%0.6 $10.39 7/31/2022297,200 shares $2.40 million -29.0%23.0%1 $8.09 7/15/2022418,400 shares $3.87 million +59.8%32.4%1.3 $9.24 6/30/2022261,800 shares $2.22 million -28.7%20.3%1.8 $8.47 6/15/2022367,000 shares $2.98 million +5.6%10.1%2.8 $8.12 5/31/2022347,500 shares $2.69 million +12.7%11.3%3.2 $7.74 5/15/2022308,400 shares $2.99 million +3.4%10.1%4.4 $9.69 4/30/2022298,300 shares $3.53 million +8.9%9.7%4.4 $11.85 4/15/2022273,900 shares $4.70 million -14.3%3.1%4 $17.16 3/31/2022319,500 shares $6.27 million +59.8%3.6%4.9 $19.62 3/15/2022200,000 shares $4.27 million +7.2%2.2%2.6 $21.33 2/28/2022186,500 shares $3.63 million +1.3%2.0%2.5 $19.49 2/15/2022184,200 shares $3.55 million +25.7%2.0%2.6 $19.26 1/31/2022146,500 shares $2.71 million +67.2%1.6%2.5 $18.47 1/15/202287,600 shares $1.77 million -18.4%N/A1.7 $20.24 12/31/2021107,300 shares $2.61 million -2.7%1.2%2.4 $24.33 12/15/2021110,300 shares $2.91 million +3.6%1.1%2.8 $26.36 11/30/2021106,500 shares $3.35 million +24.9%3.9%3.2 $31.43 11/15/202185,300 shares $2.99 million -21.2%3.1%2.3 $35.11 10/29/2021108,300 shares $3.83 million -7.1%4.0%3 $35.36 10/15/2021116,600 shares $4.43 million -49.4%4.4%3 $37.96 9/30/2021230,300 shares $9.00 million +72.3%9.2%5.4 $39.07 9/15/2021133,700 shares $5.59 million -11.0%5.3%2 $41.82 8/31/2021150,300 shares $6.02 million -18.1%6.0%1.9 $40.02 8/13/2021183,500 shares $7.43 million -10.5%7.5%1.8 $40.50 7/30/2021205,100 shares $8.10 million +3.1%8.4%1.9 $39.47 7/15/2021199,000 shares $8.34 million +2.4%8.2%1.6 $41.92 6/30/2021194,400 shares $8.74 million +63.5%8.0%1 $44.94 6/15/2021118,900 shares $4.72 million -12.6%4.9%0.3 $39.73 5/28/2021136,000 shares $5.04 million -4.2%5.6%0.3 $37.08 5/14/2021142,000 shares $4.51 million +15.5%5.9%0.2 $31.78 4/30/2021122,900 shares $4.69 million -61.3%5.2%0.2 $38.17 4/15/2021317,500 shares $11.23 million +65.5%13.3%0.5 $35.36 3/31/2021191,900 shares $6.31 million -21.3%11.4%0.3 $32.90 3/15/2021243,900 shares $7.10 million +218.8%14.4%0.5 $29.12 2/26/202176,500 shares $2.50 million +58.4%4.8%0.1 $32.63 2/12/202148,300 shares $1.93 million +20.5%3.1%0.1 $39.98 1/29/202140,100 shares $1.37 million -20.9%2.5%0 $34.20 1/15/202150,700 shares $1.82 million No Change3.2%0.1 $35.90 GLSI Short Interest - Frequently Asked Questions What is Greenwich LifeSciences' current short interest? Short interest is the volume of Greenwich LifeSciences shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 177,100 shares of GLSI short. 3.03% of Greenwich LifeSciences' shares are currently sold short. Learn More on Greenwich LifeSciences' current short interest. What is a good short interest ratio for Greenwich LifeSciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLSI shares currently have a short interest ratio of 4.0. Learn More on Greenwich LifeSciences's short interest ratio. What is a good short interest percentage for Greenwich LifeSciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.03% of Greenwich LifeSciences' floating shares are currently sold short. Is Greenwich LifeSciences' short interest increasing or decreasing? Greenwich LifeSciences saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 177,100 shares, a decline of 6.3% from the previous total of 189,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Greenwich LifeSciences' float size? Greenwich LifeSciences currently has issued a total of 12,880,000 shares. Some of Greenwich LifeSciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Greenwich LifeSciences currently has a public float of 5,850,000 shares. How does Greenwich LifeSciences' short interest compare to its competitors? 3.03% of Greenwich LifeSciences' shares are currently sold short. Here is how the short interest of companies compare to Greenwich LifeSciences: Puma Biotechnology, Inc. (8.63%), ALX Oncology Holdings Inc. (11.56%), Calliditas Therapeutics AB (publ) (0.03%), Dianthus Therapeutics, Inc. (10.17%), Silence Therapeutics plc (1.94%), AnaptysBio, Inc. (18.36%), Harrow, Inc. (14.08%), Pharming Group (0.01%), Arbutus Biopharma Co. (2.83%), Phathom Pharmaceuticals, Inc. (43.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Greenwich LifeSciences stock? Short selling GLSI is an investing strategy that aims to generate trading profit from Greenwich LifeSciences as its price is falling. GLSI shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Greenwich LifeSciences? A short squeeze for Greenwich LifeSciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLSI, which in turn drives the price of the stock up even further. How often is Greenwich LifeSciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLSI, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Puma Biotechnology Short Interest Data ALX Oncology Short Interest Data Calliditas Therapeutics AB (publ) Short Interest Data Dianthus Therapeutics Short Interest Data Silence Therapeutics Short Interest Data AnaptysBio Short Interest Data Harrow Short Interest Data Pharming Group Short Interest Data Arbutus Biopharma Short Interest Data Phathom Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLSI) was last updated on 5/29/2024 by MarketBeat.com Staff From Our Partners4 Cryptos BETTER than BitcoinTrue Market InsidersWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyHow Biden has already won 2024Porter & CompanyNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss Ratings41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.